Boston Scientific
BSX
41.58
-0.61
-1.45%
Boston Scientific
US · BSX
#364 by market cap
Listed 1970
41.58
-0.61
-1.45%
Live - 5344 symbols - heartbeat 29s ago
· 2026-10-08 07:00
Pre-market
41.57
-0.02%
After-hours
41.70
+0.29%
Overnight
41.64
+0.14%
- Market cap
- 60.26B
- P/E (TTM)i
- 16.83
- P/Bi
- 2.42
- EPSi
- 1.94
- Div yieldi
- 0.00%
- 52W posi
- 0%
Reader sentiment
Are you bullish or bearish on BSX?
Anonymous reader poll. Unscientific, not investment advice.
About Boston Scientific
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
- Founded
- 1979
- CEO
- Mr. Michael F. Mahoney
- Employees
- 59,000
- Headquarters
- Marlborough, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- bostonscientific.com
Company profile
- Exchange
- US
- Symbol
- BSX
- Market-cap rank
- #364
- Listing date
- 1970-01-01
- Market cap
- 60.26B
- Float cap
- 60.08B
- Shares out
- 1.45B
- Float shares
- 1.44B
Sectors & themes
Brain-Computer Interface
Medical Devices
Global medical industry
Regular Savings Plan
Fractional Shares JP
Quote time 2026-10-08 07:00:10 · For reference only, not investment advice and not tailored to your situation.